StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Harvard Bioscience's price to book ratio was 5.9× on Nov 11, 2026, against 2.4× a year earlier. Over the last 5 years it ranged from 0.2× to 5.9×, with a median of 2.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.9×+3.8
2025Dec 31, 20252.1×+0.7
2024Dec 31, 20241.4×−1.7
2023Dec 29, 20233.1×+1.5
2022Dec 30, 20221.6×−2.1
2021Dec 31, 20213.7×+1.6
2020Dec 31, 20202.2×+0.7
2019Dec 31, 20191.5×+0.0
2018Dec 31, 20181.5×−0.0
2017Dec 29, 20171.5×+0.1
2016Dec 30, 20161.4×+0.1
2015Dec 31, 20151.2×−0.6
2014Dec 31, 20141.9×+0.6
2013Dec 31, 20131.3×+0.1
2012Dec 31, 20121.3×+0.1
2011Dec 30, 20111.1×−0.5
2010Dec 31, 20101.6×–

More Harvard Bioscience figures

See a number that looks wrong?